USANA Health Sciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Inventories

Inventories

3 Months Ended

Mar. 30, 2013

NOTE D – INVENTORIES


Inventories consist of the following:
	December 28,	March 29,
	2013	2014

Raw materials	$ 13,824	$ 12,975
Work in progress	8,147	8,585
Finished goods	25,271	25,330

	$ 47,242	$ 46,890

- Definition

The entire disclosure for inventory. This may include, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the major classes of inventory, and the nature of the cost elements included in inventory. If inventory is stated above cost, accrued net losses on firm purchase commitments for inventory and losses resulting from valuing inventory at the lower-of-cost-or-market may also be included. For LIFO inventory, may disclose the amount and basis for determining the excess of replacement or current cost over stated LIFO value and the effects of a LIFO quantities liquidation that impacts net income.

+ References + Details